Inhibiting HTLV-1 Protease: A Viable Antiviral Target

Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that can cause severe paralytic neurologic disease and immune disorders as well as cancer. An estimated 20 million people worldwide are infected with HTLV-1, with prevalence reaching 30% in some parts of the world. In stark contrast to...

Full description

Saved in:
Bibliographic Details
Published in:ACS Chem Biol
Main Authors: Lockbaum, Gordon J., Henes, Mina, Talledge, Nathaniel, Rusere, Linah N., Kosovrasti, Klajdi, Nalivaika, Ellen A., Somasundaran, Mohan, Ali, Akbar, Mansky, Louis M., Yilmaz, Nese Kurt, Schiffer, Celia A.
Format: Artigo
Language:Inglês
Published: 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8126997/
https://ncbi.nlm.nih.gov/pubmed/33619959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschembio.0c00975
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items